Barrenjoey Markets initiated on Neuren yesterday with a comprehensive 46 page report.
They conclude the recent weakness is overdone and provides an opportunity to invest.
Price Target is $29.30 with a $60 unrisked valuation.
Summary below with a comment on NNZ2591
![]()
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Neuren Media and Analyst Coverage, page-1465
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.756B |
Open | High | Low | Value | Volume |
$13.50 | $14.20 | $12.96 | $6.110M | 443.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 317 | $14.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.21 | 1071 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 264 | 14.140 |
3 | 546 | 14.130 |
8 | 686 | 14.120 |
4 | 1113 | 14.110 |
5 | 1509 | 14.100 |
Price($) | Vol. | No. |
---|---|---|
14.160 | 202 | 2 |
14.170 | 1323 | 6 |
14.180 | 1541 | 6 |
14.190 | 3545 | 6 |
14.200 | 2256 | 7 |
Last trade - 13.53pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online